bearish

AFT Pharmaceuticals (AFT): 1H23 Result – Initial Impressions

275 Views01 Dec 2022 08:01
Broker
AFT Pharmaceuticals (AFT) reported a below expectations 1H23 result with EBIT ex licensing income (underlying EBIT) of NZ$3.4m versus our NZ$5.0m expectation; the key miss relative to our expectations is higher costs and lower gross margins, but we are encouraged by the strong underlying revenue trends (particularly in ANZ) with revenue ahead of our forecasts (NZ$65.8m versus our NZ$61.7m expected)
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 2-minute read)
Discussions
(Paid Plans Only)
chart-bar
Logo
Forsyth Barr
New Zealand Professional Investment Services Firm
New ZealandEquity Bottom-Up
Price Chart(Sign Up to Access)
analytics-chart
  • Loading...
x